Health Care & Life Sciences » Pharmaceuticals | Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is December-November. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
108,135
107,837
109,829
120,022
130,480
133,943
Cost of Goods Sold (COGS) incl. D&A
64,013
63,089
62,745
61,993
69,079
70,774
Gross Income
44,123
44,748
47,084
58,029
61,401
63,169
SG&A Expense
41,483
41,976
44,893
54,969
58,811
60,808
EBIT
2,187
2,253
1,706
-
1,282
1,786
Non Operating Income/Expense
455
284
3,747
815
872
173
Interest Expense
974
684
556
604
845
727
Pretax Income
1,151
1,570
5,011
1,483
1,575
1,025
Income Tax
309
140
3,438
87
116
95
Equity in Affiliates
-
38
22
-
-
-
Consolidated Net Income
1,460
1,468
1,594
1,397
1,458
1,120
Net Income
1,415
1,468
1,594
1,397
1,458
1,120
Net Income After Extraordinaries
1,415
1,468
1,594
1,397
1,458
1,120
Net Income Available to Common
1,415
1,468
1,594
1,397
1,458
1,120
EPS (Basic)
58.45
61.37
66.24
55.52
62.00
40
Basic Shares Outstanding
24
24
24
25
24
28
EPS (Diluted)
58.78
60.99
66.11
55.71
61.51
40.13
Diluted Shares Outstanding
24
24
24
25
24
28
EBITDA
4,298
4,162
3,671
3,229
3,807
4,608
Other Operating Expense
453
519
485
2,069
1,308
576
Non-Operating Interest Income
392
285
113
116
24
69
Minority Interest Expense
45
-
-
-
-
-
Equity in Affiliates (Pretax)
-
-
-
166
241
70

About Hyundai Pharmaceutical Co.

View Profile
Address
55 Jandari-gil
Cheonan SC 31213
Korea, Republic Of
Employees -
Website http://www.hyundaipharm.co.kr
Updated 07/08/2019
Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.